Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Irinotecan and Temozolomide in Pediatric Medulloblastoma and High-Grade Glioma
NCT00404495Phase 2Completed
- Sponsor
- Pfizer
- Start
- Apr 2007
- Primary completion
- Jan 2011
- Modality
- Small Molecules
- Countries
- 8
01
Overview
A Phase 2 trial of irinotecan in medulloblastoma, glioma, sponsored by Pfizer. Started Apr 2007; status: completed.
02
Drugs
irinotecan
03
Conditions
medulloblastomaglioma
Beyond the preview
Go deeper on NCT00404495.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00404495.